Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia

Blood Adv (2021) 5 (22): 4686–4690.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals